Newly surfaced stock disclosures reveal that lawmakers in the U.S. Congress made purchases of SpaceX stock in the immediate aftermath of the company's highly anticipated initial public offering (IPO). The trades, which represent the first known congressional activity in SpaceX shares, were made by Representatives Ro Khanna and Joaquin Castro, as well as Senator Catherine Cortez Masto, according to filings reviewed by CNBC.
These transactions occurred between late 2021 and early 2022, a period following SpaceX's significant valuation increase, though the company has yet to officially file for an IPO with the Securities and Exchange Commission (SEC). The exact timing and details of how these lawmakers acquired the shares remain unclear, as private stock purchases by members of Congress can be complex and are not always publicly disclosed in real-time like traditional IPOs. The reports of these purchases come at a time of increased scrutiny over congressional stock trading practices, with ongoing debates about potential conflicts of interest and the need for greater transparency. The STOCK Act, enacted in 2012, requires members of Congress to disclose stock trades within 45 days, but the intricacies of private company investments can sometimes lead to delayed or less straightforward reporting.
The implications of these disclosures extend beyond just individual lawmakers. They highlight the growing influence and financial significance of private companies like SpaceX, which has achieved unprecedented valuations without being subject to the same public reporting requirements as publicly traded entities. This raises questions about the fairness of access to investment opportunities and whether members of Congress have an informational advantage when trading in companies that may be regulated by or interact with their respective committees. As the debate around legislative ethics and financial transparency continues, these SpaceX stock buys will undoubtedly fuel further discussion on Capitol Hill.
What does the increasing involvement of lawmakers in private company investments mean for the future of congressional ethics and public trust?